- Home
- SLND vs BWAY Comparison
SLND vs BWAY Comparison
Compare SLND & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLND
- BWAY
- Stock Information
- Founded
- SLND 1900
- BWAY 2003
- Country
- SLND United States
- BWAY Israel
- Employees
- SLND N/A
- BWAY N/A
- Industry
- SLND Military/Government/Technical
- BWAY Medical/Dental Instruments
- Sector
- SLND Industrials
- BWAY Health Care
- Exchange
- SLND Nasdaq
- BWAY Nasdaq
- Market Cap
- SLND 175.8M
- BWAY 201.1M
- IPO Year
- SLND N/A
- BWAY 2019
- Fundamental
- Price
- SLND $3.80
- BWAY $12.33
- Analyst Decision
- SLND Strong Buy
- BWAY Strong Buy
- Analyst Count
- SLND 1
- BWAY 2
- Target Price
- SLND $5.00
- BWAY $14.25
- AVG Volume (30 Days)
- SLND 47.1K
- BWAY 44.0K
- Earning Date
- SLND 08-11-2025
- BWAY 08-05-2025
- Dividend Yield
- SLND N/A
- BWAY N/A
- EPS Growth
- SLND N/A
- BWAY N/A
- EPS
- SLND N/A
- BWAY 0.08
- Revenue
- SLND $931,568,000.00
- BWAY $43,457,000.00
- Revenue This Year
- SLND $3.76
- BWAY $351.53
- Revenue Next Year
- SLND $1.08
- BWAY $21.84
- P/E Ratio
- SLND N/A
- BWAY $60.06
- Revenue Growth
- SLND N/A
- BWAY 26.86
- 52 Week Low
- SLND $1.85
- BWAY $5.67
- 52 Week High
- SLND $4.93
- BWAY $12.65
- Technical
- Relative Strength Index (RSI)
- SLND 50.65
- BWAY 71.09
- Support Level
- SLND $3.66
- BWAY $10.84
- Resistance Level
- SLND $4.28
- BWAY $11.40
- Average True Range (ATR)
- SLND 0.22
- BWAY 0.54
- MACD
- SLND -0.02
- BWAY 0.08
- Stochastic Oscillator
- SLND 42.94
- BWAY 86.89
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.